Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pharma Equity Group AS's Enterprise Value is kr115.58 Mil.
Pharma Equity Group AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-23.86 Mil. Therefore, Pharma Equity Group AS's EV-to-EBIT ratio for today is -4.84.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pharma Equity Group AS's Enterprise Value is kr115.58 Mil.
Pharma Equity Group AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-23.55 Mil. Therefore, Pharma Equity Group AS's EV-to-EBITDA ratio for today is -4.91.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Pharma Equity Group AS (OCSE:PEG) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharma Equity Group AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was kr-23.86 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Pharma Equity Group AS's EV-to-EBITDA for today is:
Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharma Equity Group AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was kr-23.55 Mil.
Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharma Equity Group AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was kr0.00 Mil.
Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharma Equity Group AS's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was kr-17.66 Mil.
Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pharma Equity Group AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was kr-17.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Equity Group AS Enterprise Value Related Terms
Pharma Equity Group AS Enterprise Value Historical Data
* Premium members only.
The historical data trend for Pharma Equity Group AS's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:PEG vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Pharma Equity Group AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Equity Group AS Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pharma Equity Group AS's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Pharma Equity Group AS's Enterprise Value falls into.
Pharma Equity Group AS Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Pharma Equity Group AS's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of kr115.58 Mil mean?
Pharma Equity Group AS (OCSE:PEG) has a Enterprise Value of kr115.58 Mil as of Jul. 02, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pharma Equity Group AS and its competitors.
Is Pharma Equity Group AS's Enterprise Value too high?
Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil.
How does Pharma Equity Group AS's Enterprise Value compare to VRTX and REGN?
Pharma Equity Group AS's Enterprise Value of kr115.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pharma Equity Group AS and its competitors. Pharma Equity Group AS's current Enterprise Value is kr115.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Equity Group AS stock overvalued right now?
Pharma Equity Group AS (OCSE:PEG) has a current Enterprise Value of kr115.58 Mil. The current Enterprise Value is kr115.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Pharma Equity Group AS (OCSE:PEG), the current Enterprise Value is kr115.58 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:PEG has been successfully added to your 